We believe innovation is a team sport that requires varied perspectives and skillsets.

Our people are our greatest success

Our leadership has worked together on numerous projects throughout the years, creating a strong foundation of trust, collaboration, and shared personal values.
The result is a diverse culture of productivity and accountability, engineering and insight, focus and freedom—all working together toward a common goal of next-level results.

Not only does this unique dynamic allow us to push our everyday work forward, but it also creates a genuine sense of camaraderie that extends beyond the lab.

 

AN EXCEPTIONAL TEAM WITH STRATEGIC AND TACTICAL EXECUTION

We love what we do and we’re good at it. Our culture of innovation drives our performance each and every day.

Amr Salahieh

Founding President & CEO
Shifamed

Amr Salahieh

Founding President & CEO
Shifamed

Amr is a seasoned medical device entrepreneur with over 25 years of experience in the medical device industry. Amr is the founder of Shifamed LLC, a Silicon Valley-based medical device incubator founded in 2009, from which Legacy Portfolio Companies Maya Medical, Kalila Medical, and Apama Medical have successfully exited and through which three additional companies are currently under incubation. Prior to founding Shifamed, Amr founded Sadra Medical, a percutaneous aortic valve replacement company, which was sold to Boston Scientific in 2011 and co-founded Embolic Protection, Inc. (EPI) which was sold to Boston Scientific in 2001. Amr has extensive R&D management experience stemming from his engineering consulting firm, Sobek Medical LLC which he sold to EPI, and from his work at CardioThoracic Systems and Guidant. Amr is either the inventor or co-inventor on >100 granted and >140 published US patent applications. He holds a B.S. in Biomedical Engineering and a B.S. in Electrical Engineering from Case Western Reserve University.

Mariam Maghribi

President & CEO
Atia Vision

Chief Business Officer
Shifamed

Mariam Maghribi

President & CEO
Atia Vision

Chief Business Officer
Shifamed

Mariam has over fifteen years of experience in increasingly responsible roles within business strategy, finance, R&D, and operations in the medical device and diagnostic sectors. Currently, she is Chief Business Officer of Shifamed and CEO of Atia Vision, a portfolio company of Shifamed. Prior to Shifamed, she served as the Chief Operating Officer for deltaDOT QSTP-LLC, a joint venture between Imperial College of London and Qatar Foundation. Prior to that, she was Principal Engineer at Johnson & Johnson, where she co-founded JJ MeMs, an early stage medical microsystems incubator. Prior to Johnson & Johnson, Mariam was a Research Scientist at the Center for Micro and Nano Technology at Lawrence Livermore National Laboratories where she was a technical lead on the Department of Energy’s Retinal Prosthesis Project. Mariam is an inventor on 21 issued US patents. She holds a B.S. degree from the Georgia Institute of Technology and a Ph.D. in Biomedical engineering from University of California, Davis. She also earned dual M.B.A degrees from Columbia Business School and the UC Berkeley Haas School of Business.

Todor Jeliaskov

President & CEO
NuVera Medical

Todor Jeliaskov

President & CEO
NuVera Medical

Todor has over 20 years of experience solving customer’s needs and generating returns for investors and shareholders at large, complex enterprises, as well as start-up organizations, across continents and in a variety of industries. Currently, he is President and CEO of NuVera Medical, a Shifamed Portfolio Company. Before Shifamed, Todor served as VP at GE Global Ultrasound, the worldwide market leader in diagnostic ultrasound, and led the $500M probes business. Previously, he was CEO of the nationwide Caterpillar dealership in Bulgaria where he tripled Caterpillar’s market share in four years. He has held several senior and staff engineering positions in progressive leadership roles at Siemens Medical Solutions. Todor started his career as a design engineer at Akasol, Germany, which dominated the world championship for solar-powered racing cars between 1990 and 1992. Todor is inventor and co-inventor of more than 20 medical technology patents and author of numerous technical publications. Todor holds a Ph.D. in Electrical Engineering from the Johannes Kepler University in Linz, Austria and M.S. degree in Mechatronics from the Technical University of Darmstadt, Germany. He earned his MBA degree from the Albers School of Business and Economics at Seattle University, WA.

Jean Orth

Chief Strategy Officer
Shifamed

Jean Orth

Chief Strategy Officer
Shifamed

Leveraging her successful track record with NuVera and Supira, Jean was appointed Shifamed’s Chief Strategy Officer in March 2019. As CSO, Jean’s efforts are primarily directed toward identifying and fostering the next generation of NewCos as Shifamed continues to evolve its pipeline of innovation. Previously, Jean served as founding CEO of Supira Medical where she led the company from early stage concept development through the close of its $15.5M Series A financing in April 2018 and pivotal Proof-of-Concept milestone at the end of 2018. Prior to the formation of Supira, Jean was Executive VP of Business Development for Shifamed, where she played a key role in the early stage incubation and Series A fundraising of NuVera Medical, a sister Shifamed Portfolio Company. Previously, Jean served as a strategic marketing consultant for Shifamed’s legacy portfolio companies Maya Medical and Kalila Medical.

 

Jean began her career as an angioplasty catheter engineer for Advanced Cardiovascular Systems (Guidant/Abbott Vascular), and subsequently held various engineering and marketing management positions at EndoSonics Corporation (JOMED/Volcano) and Abbott Laboratories Critical Care Division before starting her own strategic marketing business. Jean holds an MBA with a Marketing Concentration from Santa Clara University and a B.S. degree in Mechanical Engineering from California Polytechnic State University.

Mike Dineen

President & CEO
Tioga Medical

Mike Dineen

President & CEO
Tioga Medical

Mike is President and CEO of Tioga Medical, a Shifamed-founded and incubated company focused on the mitral and tricuspid valve replacement.  Previously he was CEO of Kalila Medical, a Shifamed portfolio company where he led the company from early prototype through regulatory approvals and successful product launch.  He also led Kalila’s successful acquisition by Abbott Laboratories and FTC-mandated divestiture to Terumo Medical.  Before Kalila, he was VP of Business Development for Maya Medical, another Shifamed portfolio company that was acquired by Covidien (now Medtronic), VP of Marketing for Aragon Surgical (acquired by Aesculap), and VP of Marketing for Concentric Medical (acquired by Stryker).  Previously he was a cofounder, board member and VP of marketing, business development, clinical and regulatory affairs at Aspire Medical, a minimally invasive implant for obstructive sleep apnea (acquired by Phillips/Respironics); he also held marketing or sales roles at Radiant Medical, Target Therapeutics (acquired by Boston Scientific, now Stryker), Devices for Vascular Intervention/Guidant, and The Upjohn Company (now Pfizer).  He is a named inventor on 27 issued US patents and holds a B.S. in Biology and an M.B.A from Santa Clara University.

 

Marwan Berrada

Executive In Residence
Shifamed

Marwan Berrada

Executive In Residence
Shifamed

Marwan is currently Executive in Residence at ShifaMed incubating and building the next Shifamed portfolio company.  Previously, Marwan held a position at the Cleveland Clinic Foundation as Sr. Director, Product Development with responsibilities to resolve clinical unmet needs within the Heart and Vascular Institute and spinning out either projects or companies. In addition, he was part of the commercialization funding committee for the Global Cardiovascular Innovation Center.  Product expertise has been in percutaneous therapies such as electrophysiology, structural heart, cardiovascular and endovascular devices, in addition to product commercialization of orthopedic implants. Through his engineering and business backgrounds, Marwan is experienced in leading both traditional and virtual R&D teams throughout the entire development life-cycle including 510k and PMA regulatory tracks.  He has held various technical/engineering, managerial, and executive management positions in companies such as Microvena, ev3, CryoCath Technologies, Bavaria Medical Technologies, Vascular NanoTransfer, and OligoMedic. Currently, Marwan holds nine (9) patents in medical devices and more than thirteen (13) others as patent applications.  Marwan has a Bachelor’s and Master’s degree in Mechanical Engineering from the University of Minnesota and an MBA in Finance from McGill University.

Claudio Argento

Chief Technology Officer
Shifamed

Claudio Argento

Chief Technology Officer
Shifamed

Claudio has over 20 years of experience in Research & Development in the medical device industry. Prior to joining Shifamed, Claudio was Senior Director of R&D at PowerVision Lens, where he led the development of an accommodating intra-ocular lens.  Prior to that, Claudio was VP of R&D of BioVentrix, where he led the development of an implantable treatment for congestive heart failure. Claudio was the Director of R&D of Sadra Medical, where he developed a transcatheter aortic valve, which was acquired by Boston Scientific for $450 million in January 2011. Claudio is an inventor/co-inventor of 21 US/OUS issued patents. Claudio holds a B.S. from Rio de Janeiro Brazil, a Masters of Science from Institute National Polytechnique Grenoble France, and a Ph.D from Universite Joseph Fourier Grenoble France, all in Mechanical Engineering

Debbie White

Sr. VP, HR & Administration
Shifamed

Debbie White

Sr. VP, HR & Administration
Shifamed

Debbie has over 25 years of experience establishing and managing innovative corporate infrastructures and systems within the medical device industry. Debbie is recognized as a human resources and administrative start-up expert and an integral part of the management team for both initial public offerings and corporate acquisitions.  Currently Debbie serves as Sr. VP of Human Resources and Administration for Shifamed and its portfolio companies.  Prior to joining Shifamed, Debbie was VP of Human Resources and Administration at Benvenue Medical.  Prior to Benvenue Medical, Debbie led the human resources and administration functions at various medical device start-ups including Spiracur Inc. (acquired by Kinetic Concepts), Cryovascular Systems, Inc. (acquired by Boston Scientific) and CardioThoracic Systems, Inc. (acquired by Guidant following IPO).  Debbie holds a B.A. degree in Sociology from the University of California, Santa Cruz.

 

Robert Edesess

VP, Intellectual Property
Shifamed

Robert Edesess

VP, Intellectual Property
Shifamed

Robert has over 15 years of experience advising both large companies and startups in the life sciences field. Robert previously served as Assistant General Counsel, Intellectual Property for Thoratec Corporation, a global leader in pump technology to address advanced heart failure, prior to its acquisition by St. Jude Medical for $3.4 billion and St. Jude’s subsequent acquisition by Abbott one year later for $25 billion. At Thoratec, Robert led a turnaround of the IP function as the company doubled revenues and launched two major products. At Abbott, Robert was part of the IP Litigation group where he was responsible for managing high-impact IP and technology cases. Prior to Thoratec and Abbott, Robert worked at a global law firm and a medtech patent boutique firm where he successfully advised a number of startups through successful exits. Robert has a B.S. in Mechanical Engineering from Tufts University and a J.D. and M.B.A. from DePaul University.

David Voris

Chief Financial Officer
Shifamed

David Voris

Chief Financial Officer
Shifamed

David joined Shifamed as Chief Financial Officer in January of 2019 and serves as the CFO for each of Shifamed’s portfolio companies.  He brings over 25 years of experience in financial and operating executive leadership roles for early-stage and mid-sized medical device and life science companies. His experience includes a significant number of equity, debt, and shareholder liquidity transactions, the establishment and oversight of financial and operating controls and information systems that enable rapid scaling, and direct operational accountability.  Most recently David served as CFO and COO of Optovue, Inc.  a medical device company that rapidly emerged as a leader in Ophthalmology imaging.  David also served as CFO for Laser Diagnostic Technologies up until its sale to Carl Zeiss Meditech. David is a certified public accountant and began his career at Deloitte in the Emerging Business Services group.

Katie Arnold

Marketing Strategy
Sprig Consulting

Katie Arnold

Marketing Strategy
Sprig Consulting

Katie has 20 years of experience in healthcare and has worked with a variety of medical technology companies ranging from venture-backed start-ups to Fortune 500 companies. Katie founded and leads SPRIG Consulting, LLC providing strategic marketing services. Katie works closely with the Shifamed team on strategic marketing and branding initiatives. Key projects with Shifamed and its companies have included development of the Shifamed website as well as consulting on market development, investor presentations and commercialization strategies. Prior to founding SPRIG, Katie’s career included sales and marketing roles with Guidant Corporation and Kensey Nash Corporation. Katie holds an MBA from Northwestern University’s Kellogg Graduate School of Management and a B.A. from the University of Vermont. Currently, Katie is a Kellogg lecturer and teaches the course medical product commercialization to future healthcare leaders.

Make an Impact

Our team shares a passion for developing innovative medical technologies that improve patients’ lives. If you are seeking a dynamic environment where you can make a real impact, Shifamed may be a good fit for you.

“I am grateful that what I think and what I do matters and that my work helps to improve the lives of patients around the world. I’m proud to be a part of the Shifamed family.”

“Our state-of-the-art campus allows us to design, develop, test, and learn with incredible efficiency. As a result, we rapidly iterate ideas for next-gen devices and quickly move our technology from concept to clinical reality.”

“As an engineer, I’m a process-oriented person. It is evident that every step of Shifamed’s innovation process has been streamlined and validated to reduce inefficiencies and maximize the product development cycle.”